<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Prospective Grant of Evaluation Option Exclusive License: Development of Granulysin Immunotherapy</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Prospective Grant of Evaluation Option Exclusive License: Development of Granulysin Immunotherapy</h1>
    <p class="timestamp">Published: 2014-07-11 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>This is notice, in accordance with 35 U.S.C. 209 and 37 CFR 404, that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive evaluation option license to practice the inventions embodied in U.S. Provisional Patent Application. No. 61/250,601, filed October 12, 2009, HHS Ref. No.: E-158-2009/0-US-01, Titled: "Granulysin Immunotherapy"; International Application No. PCT/US2010/052036, filed October 8, 2010, HHS Ref. No.: E-158-2009/0-...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, National Institutes of Health</p>
    <p><strong>Document Number:</strong> 2014-16267</p>
    <p><strong>Publication Date:</strong> 2014-07-11</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2014/07/11/2014-16267/prospective-grant-of-evaluation-option-exclusive-license-development-of-granulysin-immunotherapy">https://www.federalregister.gov/documents/2014/07/11/2014-16267/prospective-grant-of-evaluation-option-exclusive-license-development-of-granulysin-immunotherapy</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2014-16267</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
